Tesamorelin

Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) that has attracted significant scientific interest due to its ability to stimulate endogenous growth hormone secretion.

It has been extensively studied for its interaction with GHRH receptors, growth hormone regulation and metabolic processes involving visceral adipose tissue.

Researchers investigate Tesamorelin in laboratory and clinical research settings examining pituitary hormone activity, insulin-like growth factor 1 (IGF-1) signalling, body composition and metabolic regulation.

Key Features

✓ Studied for its interaction with GHRH receptor pathways
✓ Investigated in growth hormone secretion research
✓ Explored in visceral adipose tissue studies
✓ Researched in IGF-1 signalling pathways
✓ Studied in endocrine and metabolic regulation
✓ Relevant to body composition and adipose tissue research

GHRH Receptor Research

Tesamorelin acts as a GHRH analogue, interacting with growth hormone-releasing hormone receptors in the anterior pituitary gland.

Research examines how this interaction influences endogenous growth hormone secretion and the regulation of the somatotropic axis.

Growth Hormone & IGF-1 Research

Tesamorelin is investigated for its influence on growth hormone release and subsequent IGF-1 signalling.

Researchers explore the relationship between these hormones and their involvement in cellular growth, tissue maintenance and metabolic activity.

Visceral Adipose Tissue Research

One of the major areas of scientific interest surrounding Tesamorelin involves visceral adipose tissue.

Research investigates the relationship between growth hormone signalling and visceral fat metabolism, particularly the biological mechanisms involved in adipose tissue regulation.

Metabolic Regulation Research

Researchers explore Tesamorelin in studies examining lipid metabolism, body composition and metabolic signalling pathways associated with growth hormone activity.

Scientific Research Context

Growth hormone regulation involves a complex endocrine network connecting the hypothalamus, pituitary gland and peripheral tissues.

GHRH is naturally produced by the hypothalamus and stimulates the anterior pituitary gland to release growth hormone.

Tesamorelin is a modified 44-amino-acid GHRH analogue containing a trans-3-hexenoic acid modification. Its structure makes it an important subject of research investigating:

• GHRH receptor signalling
• Growth hormone secretion mechanisms
• IGF-1 regulation
• Visceral adipose tissue biology
• Lipid metabolism
• Endocrine signalling pathways
• Body composition research
• Metabolic regulation

These research areas continue to contribute to scientific interest in Tesamorelin and its role in endocrine and metabolic medicine.

Common Research Applications

Tesamorelin is frequently investigated in research programmes involving:

• Growth hormone-releasing hormone pathways
• Pituitary hormone regulation
• IGF-1 signalling
• Visceral adipose tissue metabolism
• Lipid metabolism
• Body composition research
• Endocrine physiology
• Metabolic health research

Related Research Compounds

Researchers investigating growth hormone signalling and metabolic regulation may also study:

• Sermorelin – GHRH analogue and growth hormone secretion research.
• CJC-1295 No DAC – GHRH analogue and endocrine signalling research.
• CJC-1295 with DAC – modified GHRH analogue and prolonged growth hormone signalling research.
• Ipamorelin – growth hormone secretagogue and ghrelin receptor research.
• HGH 191aa – growth hormone receptor signalling and endocrine research.
• AOD-9604 – growth hormone fragment and lipid metabolism research.

These compounds have different molecular structures and mechanisms within endocrine and metabolic science.

Product Specifications

Product Name: Tesamorelin
Compound Type: Synthetic Peptide Analogue
Research Category: Growth Hormone & Metabolic Research
Molecular Structure: Modified 44-Amino-Acid Peptide
Primary Target: Growth Hormone-Releasing Hormone (GHRH) Receptor
Primary Research Focus: Growth Hormone Secretion & Visceral Adipose Tissue
Physical Form: Confirm against supplier specification
Available Sizes: 2mg, 5mg and 10mg Vials
Application: Scientific Research Use Only

Important Notice

For laboratory research use only. This product description is intended solely for research, analytical and educational purposes. It is not intended for unauthorised human or animal consumption, therapeutic use, veterinary use, diagnostic procedures or administration of any kind.

Tesamorelin is an approved prescription medicine in certain formulations and jurisdictions for specific medical indications, including HIV-associated lipodystrophy in the United States. Approval does not extend automatically to research-grade products or other applications.

Research-grade material should not be assumed to meet pharmaceutical manufacturing standards or be suitable for human administration.